Phase 3, open,clinical trial of NPC-02 for treatment of Wilson's disease.
Phase 3
- Conditions
- Wilson's disease
- Registration Number
- JPRN-jRCT2080220112
- Lead Sponsor
- obelpharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Wilson's disease(Adult,Infant, Pregnant woman)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy
- Secondary Outcome Measures
Name Time Method